SoftBank-Backed Synthetic Biology Startup Raises $300 Million to Build a Better Microbe
Pipettes operate on a rack of test tubes inside in Rodez, France. (Photographer: Balint Porneczi/Bloomberg)

SoftBank-Backed Synthetic Biology Startup Raises $300 Million to Build a Better Microbe

(Bloomberg) -- Synthetic biology startup Zymergen Inc. has raised $300 million in a new funding round—a signal of investors’ confidence that biological science can be harnessed in novel ways to man...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.